Published in Cancer Res on October 01, 1977
Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem (2009) 1.03
mRNAs containing the histone 3' stem-loop are degraded primarily by decapping mediated by oligouridylation of the 3' end. RNA (2012) 0.98
Peripheral administration of translation inhibitors reverses increased hyperalgesia in a model of chronic pain in the rat. J Pain (2013) 0.95
Anti-inflammatory effects of cordycepin in lipopolysaccharide-stimulated RAW 264.7 macrophages through Toll-like receptor 4-mediated suppression of mitogen-activated protein kinases and NF-κB signaling pathways. Drug Des Devel Ther (2014) 0.87
Aberrant, differential and bidirectional regulation of the unfolded protein response towards cell survival by 3'-deoxyadenosine. Cell Death Differ (2011) 0.87
Cordycepin induces cell cycle arrest and apoptosis by inducing DNA damage and up-regulation of p53 in Leukemia cells. Cell Cycle (2015) 0.84
Cytotoxic Activity of Crude Extracts as well as of Pure Components from Jatropha Species, Plants Used Extensively in African Traditional Medicine. Evid Based Complement Alternat Med (2011) 0.84
Cordycepin interferes with 3' end formation in yeast independently of its potential to terminate RNA chain elongation. RNA (2009) 0.82
Blockade of adipocyte differentiation by cordycepin. Br J Pharmacol (2012) 0.82
The Lingulodinium circadian system lacks rhythmic changes in transcript abundance. BMC Biol (2014) 0.79
Cordycepin as a sensitizer to tumour necrosis factor (TNF)-α-induced apoptosis through eukaryotic translation initiation factor 2α (eIF2α)- and mammalian target of rapamycin complex 1 (mTORC1)-mediated inhibition of nuclear factor (NF)-κB. Clin Exp Immunol (2012) 0.77
Modulation of poly(A)(+)mRNA-metabolizing and transporting systems under special consideration of microtubule protein and actin. Mol Cell Biochem (1983) 0.76
MLH1-deficient HCT116 colon tumor cells exhibit resistance to the cytostatic and cytotoxic effect of the poly(A) polymerase inhibitor cordycepin (3'-deoxyadenosine) in vitro. Oncol Lett (2011) 0.76
Characterizations of a new Cordyceps cicadae isolate and production of adenosine and cordycepin. Braz J Microbiol (2012) 0.75
Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues. Eur J Clin Microbiol (1983) 2.45
Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data. Addiction (2003) 2.06
Inhibition of replication of the etiologic agent of acquired immune deficiency syndrome (human T-lymphotropic retrovirus/lymphadenopathy-associated virus) by avarol and avarone. J Natl Cancer Inst (1987) 1.73
Four new bioactive manzamine-type alkaloids from the Philippine marine sponge Xestospongia ashmorica. J Nat Prod (1996) 1.70
Contribution of topoisomerase IV and DNA gyrase mutations in Streptococcus pneumoniae to resistance to novel fluoroquinolones. Antimicrob Agents Chemother (1999) 1.63
Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice. Neurobiol Aging (2008) 1.59
[The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates]. Arzneimittelforschung (1984) 1.50
The location of drug binding sites in human serum albumin. Biochem Pharmacol (1981) 1.48
Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity. J Antibiot (Tokyo) (1992) 1.44
The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides. Infection (1984) 1.41
Virazole (1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide; a cytostatic agent. Biochem Pharmacol (1977) 1.40
Genotoxicity of the fungicide dichlofluanid in seven assays. Environ Mol Mutagen (1991) 1.39
Inhibition of herpesvirus DNA synthesis by 9-beta-D-arabinofuranosyladenine in cellular and cell-free systems. Ann N Y Acad Sci (1977) 1.39
[Iron level in the palatal and pharyngeal tonsils]. Arch Klin Exp Ohren Nasen Kehlkopfheilkd (1968) 1.38
Action of bleomycin on DNA and RNA. Eur J Biochem (1972) 1.38
Characterization of the autoantigen La as a nucleic acid-dependent ATPase/dATPase with melting properties. Cell (1990) 1.36
Bacteria of the Genus Roseobacter Associated with the Toxic Dinoflagellate Prorocentrum lima. Protist (2009) 1.35
HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum. Arzneimittelforschung (1983) 1.27
Association of La and Ro antigens with intracellular structures in HEp-2 carcinoma cells. Proc Natl Acad Sci U S A (1986) 1.26
Hyperforin as a possible antidepressant component of hypericum extracts. Life Sci (1998) 1.25
Cefodizime, an aminothiazolyl cephalosporin. IV. Influence on the immune system. J Antibiot (Tokyo) (1984) 1.25
The La antigen shuttles between the nucleus and the cytoplasm in CV-1 cells. Mol Cell Biochem (1989) 1.23
Interferon production in patients infected with HIV-1. J Infect Dis (1989) 1.23
Characterization of an important drug binding area on human serum albumin including the high-affinity binding sites of warfarin and azapropazone. Mol Pharmacol (1982) 1.22
Isolation and transcriptional characterization of three genes which function at start, the controlling event of the Saccharomyces cerevisiae cell division cycle: CDC36, CDC37, and CDC39. Mol Cell Biol (1983) 1.19
Origin of insulin receptor-like tyrosine kinases in marine sponges. Biol Bull (1999) 1.18
Detection of human immunodeficiency virus-1 nucleic acid on inactivated filter paper disks by polymerase chain reaction and microtiter plate assay. Microbiol Immunol (1994) 1.17
Transport of mRNA from nucleus to cytoplasm. Prog Nucleic Acid Res Mol Biol (1987) 1.17
Inhibitors acting on nucleic acid synthesis in an oncogenic RNA virus. Nat New Biol (1971) 1.15
Upregulation of the 2-5A synthetase/RNase L antiviral pathway associated with chronic fatigue syndrome. Clin Infect Dis (1994) 1.14
Differential gene expression of IFN-alpha and tumor necrosis factor-alpha in peripheral blood mononuclear cells from patients with AIDS related complex and AIDS. J Immunol (1990) 1.14
Potent inhibition of hepatitis B virus production in vitro by modified pyrimidine nucleosides. Antimicrob Agents Chemother (1990) 1.12
The comparison of beta-thymosin homologues among metazoa supports an arthropod-nematode clade. J Mol Evol (2000) 1.11
Intracellular distribution of the La antigen in CV-1 cells after herpes simplex virus type 1 infection compared with the localization of U small nuclear ribonucleoprotein particles. J Gen Virol (1989) 1.11
Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells. Proc Natl Acad Sci U S A (1992) 1.11
Effects of EGb 761 Ginkgo biloba extract on mitochondrial function and oxidative stress. Pharmacopsychiatry (2003) 1.11
Expression of silicatein and collagen genes in the marine sponge Suberites domuncula is controlled by silicate and myotrophin. Eur J Biochem (2000) 1.11
Mature mRNA is selectively released from the nuclear matrix by an ATP/dATP-dependent mechanism sensitive to topoisomerase inhibitors. J Biol Chem (1987) 1.08
Formation of transmural complement pores in serum-sensitive Escherichia coli. Infect Immun (1987) 1.08
Primmorphs generated from dissociated cells of the sponge Suberites domuncula: a model system for studies of cell proliferation and cell death. Mech Ageing Dev (1998) 1.07
Phosphorylation of arabinofuranosylthymine in non-infected and herpesvirus (TK+ and TK-)-infected cells. J Gen Virol (1979) 1.06
Simple 2,4-diacylphloroglucinols as classic transient receptor potential-6 activators--identification of a novel pharmacophore. Mol Pharmacol (2009) 1.05
Inhibition of GABA and benzodiazepine receptor binding by penicillins. Neurosci Lett (1980) 1.04
Mode of action of 9-beta-D-arabinofuranosyladenine on the synthesis of DNA, RNA, and protein in vivo and in vitro. Cancer Res (1975) 1.04
ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain. J Neural Transm (Vienna) (2001) 1.03
Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region. J Biol Chem (1990) 1.03
Cellular and biochemical responses to environmental and experimentally induced stress in sea urchin coelomocytes. Cell Stress Chaperones (2000) 1.03
Separation of deoxyribonucleases (DNases) of normal human stratum corneum and psoriatic scales by micro-disc-electrophoresis. Arch Dermatol Res (1975) 1.02
DNA-dependent DNA polymerase pattern in noninfected and herpesvirus infected rabbit kidney cells. Arch Gesamte Virusforsch (1973) 1.02
Identification of the Ro and La antigens in the endoribonuclease VII--ribonucleoprotein complex. Biochem J (1987) 1.02
The conservation of poly-A-containing RNA during the dormant state of the moss Polytrichum commune. Nucleic Acids Res (1976) 1.01
Flavonoids and the aging brain. J Physiol Pharmacol (2005) 1.01
Human serum albumin as a 'silent receptor' for drugs and endogenous substances. Pharmacology (1979) 1.01
Friulimicins: novel lipopeptide antibiotics with peptidoglycan synthesis inhibiting activity from Actinoplanes friuliensis sp. nov. II. Isolation and structural characterization. J Antibiot (Tokyo) (2000) 1.01
Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin. Antimicrob Agents Chemother (1991) 1.00
Cefodizime, an aminothiazolylcephalosporin. II. Comparative studies on the pharmacokinetic behavior in laboratory animals. J Antibiot (Tokyo) (1984) 1.00
Characterization of a common binding site for basic drugs on human alpha 1-acid glycoprotein (orosomucoid). Naunyn Schmiedebergs Arch Pharmacol (1983) 1.00
Inhibition of intrinsic protein tyrosine kinase activity of EGF-receptor kinase complex from human breast cancer cells by the marine sponge metabolite (+)-aeroplysinin-1. Comp Biochem Physiol B (1990) 1.00
Potent antileukemic activity of the novel cytostatic agent avarone and its analogues in vitro and in vivo. Cancer Res (1985) 0.99
Change of processing and nucleocytoplasmic transport of mRNA in HSV-1-infected cells. Virus Res (1989) 0.99
Purification and characterization of a species-specific aggregation factor in sponges. Exp Cell Res (1973) 0.99
[Detection of several different nuclease activities in human cerebrospinal fluid (author's transl)]. Z Klin Chem Klin Biochem (1973) 0.99
Shuttling of the autoantigen La between nucleus and cell surface after uv irradiation of human keratinocytes. Exp Cell Res (1990) 0.99
Early evolution of metazoan serine/threonine and tyrosine kinases: identification of selected kinases in marine sponges. Mol Biol Evol (1997) 0.98
Protection of HeLa-T4+ cells against human immunodeficiency virus (HIV) infection after stable transfection with HIV LTR-2',5'-oligoadenylate synthetase hybrid gene. FASEB J (1990) 0.98
Cathepsin, a major protease of the marine sponge Geodia cydonium: purification of the enzyme and molecular cloning of cDNA. Mol Mar Biol Biotechnol (1997) 0.97
Sarcophytolide: a new neuroprotective compound from the soft coral Sarcophyton glaucum. Toxicology (1998) 0.97
Production of the cytostatic agent aeroplysinin by the sponge Verongia aerophoba in in vitro culture. Comp Biochem Physiol C (1992) 0.96
Studies on protein kinases involved in regulation of nucleocytoplasmic mRNA transport. Biochem J (1988) 0.96
Occurrence of novel small RNAs with concomitant inhibition of host cellular U small nuclear RNA synthesis in Vero cells infected with herpes simplex virus type 1. J Gen Virol (1986) 0.95
Bleomycin, an antibiotic that removes thymine from double-stranded DNA. Prog Nucleic Acid Res Mol Biol (1977) 0.95
S-type lectins occur also in invertebrates: high conservation of the carbohydrate recognition domain in the lectin genes from the marine sponge Geodia cydonium. Glycobiology (1993) 0.95
Detection of HIV-1 distribution in different blood fractions by two nucleic acid amplification assays. AIDS Res Hum Retroviruses (1993) 0.95
Purification and characterization of a cephalosporinase from E. coli. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.95
Chemotherapeutic effects of ofloxacin (HOE 280) and other quinolone-carboxylic derivates in the treatment of experimental lung infections due to Klebsiella pneumoniae DT-S in mice. Infection (1986) 0.95
Modulation of nuclear matrix-associated 2',5'-oligoadenylate metabolism and ribonuclease L activity in H9 cells by human immunodeficiency virus. J Biol Chem (1989) 0.95
Poly ADP-ribosylation of DNA-dependent RNA polymerase I from quail oviduct. Dependence on progesterone stimulation. Mol Cell Biochem (1976) 0.94
Decreased and variable systemic availability of zidovudine in patients with AIDS if administered with a meal. Eur J Clin Pharmacol (1991) 0.94
[An enzymic method for the determination of cefotaxim in serum and urine (author's transl)]. J Clin Chem Clin Biochem (1981) 0.94
Metabolism of 1-beta-D-arabinofuranosyluracil in mouse L5178Y cells. Cancer Res (1979) 0.94
Arabinosyl nucleosides. XIII. Influence of arabinofuranosylthymine on DNA-, RNA- and protein-synthesizing systems in vitro. Chem Biol Interact (1978) 0.94